Valeant's Last Shot to Woo Owners of Botox Maker Allergan Robert Cyran The mid-December vote on replacing a majority of Allergan’s board Is Valeant’s last best hope for its $51 billion hostile takeover. September 17, 2014 at 4:00AM http://nyti.ms/1qg87C2 http://nyti.ms/1mb1CWa The New York Times Business Day Boards of Directors, Botox (Drug), Mergers, Acquisitions and Divestitures

By Robert Cyran via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1qg87C2 Valeant's Last Shot to Woo Owners of Botox Maker Allergan September 17, 2014 at 4:00AM http://nyti.ms/1mb1CWa The New York Times